Ann-Kristin Mueller

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Unusual properties of Plasmodium falciparum actin: new insights into microfilament dynamics of apicomplexan parasites.

Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

A Plasmodium actin-depolymerizing factor that binds exclusively to actin monomers.

Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.

Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.

Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites.

Vaccines against malaria - an update.

Invasion of mosquito salivary glands by malaria parasites: prerequisites and defense strategies.

Continuous oral chloroquine as a novel route for Plasmodium prophylaxis and cure in experimental murine models.

To go, or not to go, that is the question - six personal reflections on how geographic mobility may affect your career and life.

In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.

Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model.

Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.

RNAi in Plasmodium.

A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages.

The Spatiotemporal Dynamics and Membranous Features of the Plasmodium Liver Stage Tubovesicular Network.

CD8(+) T Cells Mediate Robust Stage-Specific Immunity to P. berghei under Chemoprophylaxis and This Protective Environment Is Not Downregulated by the Presence of Blood-Stage Infection.

CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.

AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasites.

Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxis.

In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites.

Plasmodium attenuation: connecting the dots between early immune responses and malaria disease severity.

Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccination.

Chemical attenuation of Plasmodium in the liver modulates severe malaria disease progression.

Zinc finger nuclease-based double-strand breaks attenuate malaria parasites and reveal rare microhomology-mediated end joining.

Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream.

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.

Plasmodium meets AAV-the (un)likely marriage of parasitology and virology, and how to make the match.

Protective efficacy and safety of liver stage attenuated malaria parasites.

The Actin Filament-Binding Protein Coronin Regulates Motility in Plasmodium Sporozoites.

A suggested vital function for eIF-5A and dhs genes during murine malaria blood-stage infection.

Oxidative insult can induce malaria-protective trait of sickle and fetal erythrocytes.

Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development.